Cargando…
Randomised controlled trial of intermittent vs continuous energy restriction during chemotherapy for early breast cancer
BACKGROUND: Excess adiposity at diagnosis and weight gain during chemotherapy is associated with tumour recurrence and chemotherapy toxicity. We assessed the efficacy of intermittent energy restriction (IER) vs continuous energy restriction (CER) for weight control and toxicity reduction during chem...
Autores principales: | Harvie, Michelle, Pegington, Mary, Howell, Sacha J., Bundred, Nigel, Foden, Phil, Adams, Judith, Graves, Lee, Greystoke, Alastair, Mattson, Mark P., Cutler, Roy G., Williamson, Julie, Livingstone, Karen, McMullen, Debbie, Sellers, Katharine, Lombardelli, Cheryl, Cooper, Grace, McDiarmid, Sarah, Howell, Anthony |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9023522/ https://www.ncbi.nlm.nih.gov/pubmed/34912072 http://dx.doi.org/10.1038/s41416-021-01650-0 |
Ejemplares similares
-
Breast cancer risk status influences uptake, retention and efficacy of a weight loss programme amongst breast cancer screening attendees: two randomised controlled feasibility trials
por: Harvie, Michelle, et al.
Publicado: (2019) -
Testing a breast cancer prevention and a multiple disease prevention weight loss programme amongst women within the UK NHS breast screening programme—a randomised feasibility study
por: Harvie, Michelle, et al.
Publicado: (2021) -
Reply to Comment on “The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial”
por: Harvie, Michelle, et al.
Publicado: (2020) -
The effectiveness of home versus community-based weight control programmes initiated soon after breast cancer diagnosis: a randomised controlled trial
por: Harvie, Michelle, et al.
Publicado: (2019) -
Effect of intermittent versus continuous energy restriction on weight loss and breast cancer risk biomarkers
por: Harvie, M, et al.
Publicado: (2010)